Domain Partners VIII, L.P.'s Net Worth

$210 Million

Estimate Recalculated Nov 4, 2024 02:33AM EST

Who is Domain Partners VIII, L.P.

Domain Partners VIII, L.P. has an estimated net worth of $210 Million. This is based on reported shares across multiple companies, which include OTONOMY, INC., Dicerna Pharmaceuticals Inc, Bionano Genomics, Inc., GLAUKOS Corp, VERACYTE, INC., Atara Biotherapeutics, Inc., Syndax Pharmaceuticals Inc, Alliqua BioMedical, Inc., aTYR PHARMA INC, Durata Therapeutics, Inc., ACHILLION PHARMACEUTICALS INC, and Ocera Therapeutics, Inc..

SEC CIK

Domain Partners VIII, L.P.'s CIK is 0001465144

Past Insider Trading and Trends

2014 was Domain Partners VIII, L.P.'s most active year for acquiring shares with 6 total transactions. Domain Partners VIII, L.P.'s most active month to acquire stocks was the month of July. 2014 was Domain Partners VIII, L.P.'s most active year for disposing of shares, totalling 12 transactions. Domain Partners VIII, L.P.'s most active month to dispose stocks was the month of July. 2012 saw Domain Partners VIII, L.P. paying a total of $7,006,824.00 for 3,006,132 shares, this is the most they've acquired in one year. In 2014 Domain Partners VIII, L.P. cashed out on 8,627,034 shares for a total of $595,584.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc

Investor
Updated Dec 20, 2017
Form 4
92.47%
1.67M
$3.19
Dec 20, 2017
3.47M
Options
Dec 18
Form 4
49.63K
$100.00
$4.96M
Apr 12, 2017
49.63K
Purchase
Apr 11
Form 4
Feb 04, 2014
1.77M
Options
Feb 04
Form 3
Jan 29, 2014
Showing 4 results

Bionano Genomics, Inc.

Investor
Updated Aug 27, 2018
Form 4
-90.87%
-24.68M
$5.36
$1.64M
Aug 27, 2018
2.48M
Buy-Options
Aug 23
Form 3
Aug 21, 2018
Showing 2 results

GLAUKOS Corp

Investor
Updated Jul 01, 2015
Form 4
Jul 01, 2015
876.08K
Options
Jun 30
Form 3
Jun 24, 2015
Showing 2 results

Atara Biotherapeutics, Inc.

Investor
Updated Oct 21, 2014
Form 4
13.11%
248.16K
$11.00
Oct 21, 2014
2.14M
Purchase
Oct 21
Form 3
Oct 15, 2014
Showing 2 results

Syndax Pharmaceuticals Inc

Investor
Updated Mar 08, 2016
Form 4
Mar 08, 2016
761.06K
Options
Mar 08
Form 3
Mar 02, 2016
Showing 2 results

Alliqua BioMedical, Inc.

Investor
Updated May 13, 2019
Form 3
May 13, 2019
3.04M
Showing 1 results

aTYR PHARMA INC

Investor
Updated May 12, 2015
Form 4
-87.56%
-12.73M
May 12, 2015
1.81M
Options
May 12
Form 3
May 06, 2015
Showing 2 results

OTONOMY, INC.

Investor
Updated Aug 18, 2014
Form 4
-2.31%
-277.00
$12.40
-$19.42
Aug 18, 2014
11.72K
Options
Aug 18
Form 4
-2.30%
-37.22K
$12.40
-$17.55
Aug 18, 2014
1.58M
Options
Aug 18
Form 3
Aug 12, 2014
Showing 3 results

Durata Therapeutics, Inc.

Investor
Updated Nov 18, 2014
Form 4
-100.00%
-3.01M
Nov 18, 2014
Disposition
Nov 17
Form 4
34.95%
778.54K
$9.00
Jul 24, 2012
3.01M
Purchase
Jul 24
Form 3
Jul 18, 2012
Showing 3 results

Ocera Therapeutics, Inc.

Investor
Updated Dec 13, 2017
Form 4
-100.00%
-988.28K
Dec 13, 2017
Disposition
Dec 11
Form 3
Jul 16, 2013
988.29K
Showing 2 results

VERACYTE, INC.

Investor
Updated Sep 12, 2014
Form 4
-9.79%
-300.00K
Sep 12, 2014
2.76M
Disposition
Sep 10
Form 4
Nov 04, 2013
3.06M
Options
Nov 04
Form 3
Oct 29, 2013
Showing 3 results

ACHILLION PHARMACEUTICALS INC

Investor
Updated Jan 18, 2013
Form 4
-14.76%
-1.00M
Jan 18, 2013
5.77M
Disposition
Jan 18
Form 4
-15.05%
-1.20M
Jun 04, 2012
6.77M
Disposition
May 31
Form 3
Aug 23, 2010
7.97M
Showing 3 results